We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of GRAd-COV2 for the Prevention of COVID-19 in Adults (COVITAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04791423
Recruitment Status : Completed
First Posted : March 10, 2021
Last Update Posted : March 29, 2023
Sponsor:
Collaborator:
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
Information provided by (Responsible Party):
ReiThera Srl

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
Recruitment Status : Completed
Actual Primary Completion Date : June 4, 2021
Actual Study Completion Date : May 13, 2022